🇺🇸 FDA
Patent

US 8715649

Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity

granted A61KA61K38/57A61P

Quick answer

US patent 8715649 (Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/57, A61P, A61P3/10, A61P37/06